Donoghue Forlines’s Arrowhead Research ARWR Stock Holding History

Donoghue Forlines’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,823	Closed	-$519K	–	264
2021 Q4	$519K	Sell	7,823 -478	-6%	-$32.8K	0.09%	232
2021 Q3	$518K	Buy	+8,301	New	+$537K	0.1%	184
2020 Q1	–	Sell	-33,787	Closed	-$2.14M	–	67
2019 Q4	$2.14M	Buy	+33,787	New	+$1.68M	0.33%	112

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Donoghue Forlines's ARWR Position: Q1 2022 in Review

Donoghue Forlines sold out of Arrowhead Research (ARWR) in Q1 2022, closing a stake of 7,823 shares — an estimated $519K sold.

Donoghue Forlines first reported a position in ARWR in Q4 2019 and held it in 3 quarters. The position peaked at $2.14M in Q4 2019. 308 funds tracked by Wall St. Rank hold ARWR as of Q1 2022.

Donoghue Forlines reported no remaining Arrowhead Research position as of Q1 2022 after selling out during the quarter.
Donoghue Forlines sold 7,823 Arrowhead Research shares in Q1 2022, an estimated $519K.
Donoghue Forlines first reported a position in Arrowhead Research in Q4 2019 and held it in 3 quarters.
Donoghue Forlines's Arrowhead Research position peaked at $2.14M in Q4 2019.
308 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2022.

Based on Donoghue Forlines's 13F filing for Q1 2022, filed 16 May 2022.